1. Home
  2. AIP vs STRO Comparison

AIP vs STRO Comparison

Compare AIP & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIP
  • STRO
  • Stock Information
  • Founded
  • AIP 2003
  • STRO 2003
  • Country
  • AIP United States
  • STRO United States
  • Employees
  • AIP N/A
  • STRO N/A
  • Industry
  • AIP Semiconductors
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIP Technology
  • STRO Health Care
  • Exchange
  • AIP Nasdaq
  • STRO Nasdaq
  • Market Cap
  • AIP 277.9M
  • STRO 292.6M
  • IPO Year
  • AIP 2021
  • STRO 2018
  • Fundamental
  • Price
  • AIP $6.88
  • STRO $3.55
  • Analyst Decision
  • AIP Strong Buy
  • STRO Strong Buy
  • Analyst Count
  • AIP 4
  • STRO 8
  • Target Price
  • AIP $13.00
  • STRO $12.13
  • AVG Volume (30 Days)
  • AIP 57.1K
  • STRO 427.2K
  • Earning Date
  • AIP 11-05-2024
  • STRO 11-11-2024
  • Dividend Yield
  • AIP N/A
  • STRO N/A
  • EPS Growth
  • AIP N/A
  • STRO N/A
  • EPS
  • AIP N/A
  • STRO N/A
  • Revenue
  • AIP $53,300,000.00
  • STRO $169,359,000.00
  • Revenue This Year
  • AIP $7.54
  • STRO N/A
  • Revenue Next Year
  • AIP $19.47
  • STRO N/A
  • P/E Ratio
  • AIP N/A
  • STRO N/A
  • Revenue Growth
  • AIP 3.12
  • STRO 197.83
  • 52 Week Low
  • AIP $4.20
  • STRO $2.01
  • 52 Week High
  • AIP $9.54
  • STRO $6.13
  • Technical
  • Relative Strength Index (RSI)
  • AIP 42.29
  • STRO 47.82
  • Support Level
  • AIP $6.73
  • STRO $3.22
  • Resistance Level
  • AIP $7.29
  • STRO $3.57
  • Average True Range (ATR)
  • AIP 0.23
  • STRO 0.19
  • MACD
  • AIP -0.02
  • STRO -0.00
  • Stochastic Oscillator
  • AIP 18.87
  • STRO 45.21

About AIP Arteris Inc.

Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Share on Social Networks: